About the Journal

SPEDC holds the exclusive right to publish, distribute, assign, sell or license in physical, electronic or other media that may exist, all content submitted by authors and published.
Reproduction, even partial, of articles and illustrations without prior authorization from SPEDC is prohibited. Exceptions are made for the citation or transcription of small excerpts and/or figures, as long as the fundamental rules of authorial referencing are followed.
The names and addresses provided in this magazine will be used exclusively for the services provided by this publication and will not be made available for other purposes or to third parties.
The journal's editorial team undertakes to comply with the Press Law, as well as to respect the deontological and ethical principles that govern scientific research as mentioned throughout this Editorial Statute, as well as respect for the good faith of readers.
Committed to ensuring the highest ethical standards in its publications, the journal seeks to comply with the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (available at https://www.icmje.org /recommendations/), the COPE Principles of Transparency and Best Practices in Scholarly Publishing (available at https://publicationethics.org/resources/guidelines/principles-transparency-and-best-practice-scholarly-publishing) and as Core Practices, from COPE (available at https://publicationethics.org/core-practices).
The journal "Critical Patient" offers free access to its content, based on the principle that making research freely available to the public contributes to greater knowledge sharing, allowing readers to view, download, print and redistribute any article.
This open access policy is defined according to the criteria of the Directory of Open Access Journals (DOAJ), available at https://doaj.org/apply/guide/#the-type-of-open-access.
The journal publishes all its articles under the terms of the Creative Commons License CC BY-NC-ND Attribution 4.0 International (this means that authors retain copyright, but allow electronic copying, distribution and printing of published articles for non-commercial purposes). , academic or individual, by any user, without permission or payment, as long as the authorship and source are acknowledged – available at https://creativecommons.org/licenses/by-nc-nd/4.0/).
The presence of advertising referring to companies in the pharmaceutical or clinical material industry may not compromise the scientific independence of the journal, nor influence editorial decisions, so its inclusion is not contemplated.